Regional variation of hidradenitis suppurativa in the Norwegian Patient Registry during a 5‐year period may describe professional awareness of the disease, not changes in prevalence
British Journal of Dermatology2016Vol. 176(1), pp. 274–275
Citations Over TimeTop 21% of 2016 papers
Abstract
Hidradenitis suppurativa (HS) is a distinct skin disease characterised by well-defined signs, symptoms and its notorious tendency to recurrence and chronicity (1). Never the less, considerable uncertainty exists regarding its prevalence. The prevalence has been estimated over the last decades with significant degree of unexplained discrepancy, ranging from 0.05% to 8% in available studies (2). This article is protected by copyright. All rights reserved.
Related Papers
- → Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 1(2018)50 cited
- → Body Image Quality of Life in Patients with Hidradenitis Suppurativa Compared with Other Dermatological Disorders(2020)31 cited
- → Case report of hidradenitis suppurativa localized to the face in an HIV patient(2021)1 cited
- → Hidradenitis Suppurativa(2017)1 cited
- → Photodynamic Therapy for Hidradenitis Suppurativa(2011)